The PA Breast Cancer Coalition has awarded two Thomas Jefferson University researchers with $100,000 dollar grants to advance groundbreaking work in triple-negative breast cancer and immunotherapy.

Advances are reshaping treatment for small cell lung cancer, with immunotherapy and emerging options offering hope for longer survival and potential cures. Immunotherapy is changing treatment ...

Circulating tumor DNA levels a few weeks after immunotherapy initiation could help identify patients with melanoma at greatest risk for recurrence or death.A retrospective analysis showed individuals ...

DOCTOR, SEVERAL NEW TREATMENTS ARE REVOLUTIONIZING THE FIGHT AGAINST BREAST CANCER AND CHIEF OF MEDICAL ONCOLOGY AT MERCY MEDICAL CENTER, DOCTOR DAVID REISBERG IS JOINING US NOW WITH SOME MORE ...

Aug. 4 (UPI) --Findings from a study in mice suggest that using a common artificial sweetener, sucralose, could hamper certain immunotherapy treatments in cancer patients. However, for folks reluctant ...

The combination of belzutifan plus lenvatinib significantly improved outcomes for patients with clear cell renal cell carcinoma who progressed following immunotherapy compared with cabozantinib ...